US2002119582A1PendingUtilityA1
Signal enhancement of bispecific antibody-polymer probe for immunoassay use
Priority: Feb 26, 1997Filed: Feb 6, 2002Published: Aug 29, 2002
Est. expiryFeb 26, 2017(expired)· nominal 20-yr term from priority
A61K 47/62Y10S435/817C07K 2317/31A61K 31/74G01N 33/6887A61K 31/415C07K 16/18A61K 49/0002G01N 33/532G01N 33/58G01N 33/54306Y10S435/912G01N 33/53C07K 16/44
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An immunoassay method including reacting a sample from a patient with a bispecific antibody, wherein the bispecific antibody includes one antibody specific for a compound to be detected and a second antibody specific for a compound foreign to said patient sample, and subsequently reacting the patient sample with a polymer probe, wherein the polymer probe includes a compound recognized by the second antibody in the bispecific antibody complex and further includes at least two detectable signals; the bispecific antibody; and the polymer probe of the immunoassay method are disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An immunoassay method comprising
reacting a sample from a patient with a bispecific antibody, said bispecific antibody comprising
one antibody specific for a compound to be detected and
a second antibody specific for a compound foreign to said patient sample; and
subsequently reacting said sample with a polymer probe, said polymer probe comprising
a polymer backbone,
attached to said polymer backbone, a compound recognizable by said second antibody in said bispecific antibody, and
at least two detectable signal compounds further attached to said polymer backbone.
2 . The immunoassay method of claim 1 , wherein said polymer probe comprises at least ten detectable compounds.
3 . The immunoassay method of claim 1 , wherein said detectable signal in said polymer probe is selected from the group consisting of radioisotope, fluorescent probe and paramagnetic probe.
4 . The immunoassay method of claim 1 , wherein said sample from said patient is a blood or serum sample; said bispecific antibody comprises an antimyosin antibody and an antibody against DTPA; and said polymer probe is a polylysine polymer and comprises DTPA and at least 6 HRP as said detectable signal compounds.
5 . A bispecific antibody for use in an immunoassay comprising
one antibody specific for a compound to be detected in said immunoassay; and a second antibody specific for a compound foreign to a sample to be assayed in said immunoassay.
6 . A polymer probe comprising
a polymer backbone; a compound recognizable by an antibody in a bispecific antibody attached to said polymer backbone, and at least two detectable signal compounds attached to said polymer backbone. a compound recognizable by said second antibody in said bispecific antibody and at least two detectable signal compounds.Join the waitlist — get patent alerts
Track US2002119582A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.